412 related articles for article (PubMed ID: 26458449)
21. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
[TBL] [Abstract][Full Text] [Related]
22. Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies.
Cataland SR; Wu HM
Eur J Intern Med; 2013 Sep; 24(6):486-91. PubMed ID: 23739653
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic microangiopathies: from animal models to human disease and cure.
Caprioli J; Remuzzi G; Noris M
Contrib Nephrol; 2011; 169():337-350. PubMed ID: 21252531
[TBL] [Abstract][Full Text] [Related]
24. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome.
Scully M; Goodship T
Br J Haematol; 2014 Mar; 164(6):759-66. PubMed ID: 24387053
[TBL] [Abstract][Full Text] [Related]
25. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents.
Lowe EJ; Werner EJ
Semin Thromb Hemost; 2005 Dec; 31(6):717-30. PubMed ID: 16388423
[TBL] [Abstract][Full Text] [Related]
26. HUS and TTP: traversing the disease and the age spectrum.
Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and management of complement mediated thrombotic microangiopathies.
Cataland SR; Wu HM
Blood Rev; 2014 Mar; 28(2):67-74. PubMed ID: 24534133
[TBL] [Abstract][Full Text] [Related]
28. [Atypical HUS caused by complement-related abnormalities].
Yoshida Y; Matsumoto M
Rinsho Ketsueki; 2015 Feb; 56(2):185-93. PubMed ID: 25765799
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic microangiopathies: an update.
Franchini M
Hematology; 2006 Jun; 11(3):139-46. PubMed ID: 17325953
[TBL] [Abstract][Full Text] [Related]
30. Syndromes of Thrombotic Microangiopathy.
Shatzel JJ; Taylor JA
Med Clin North Am; 2017 Mar; 101(2):395-415. PubMed ID: 28189178
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic microangiopathies: towards a pathophysiology-based classification.
Coppo P; Veyradier A
Cardiovasc Hematol Disord Drug Targets; 2009 Mar; 9(1):36-50. PubMed ID: 19275576
[TBL] [Abstract][Full Text] [Related]
32. [Thrombotic microangiopathies].
Nielsen OJ; Friis-Hansen L
Ugeskr Laeger; 2009 Nov; 171(49):3614-20. PubMed ID: 19954703
[TBL] [Abstract][Full Text] [Related]
33. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.
Phillips EH; Westwood JP; Brocklebank V; Wong EK; Tellez JO; Marchbank KJ; McGuckin S; Gale DP; Connolly J; Goodship TH; Kavanagh D; Scully MA
J Thromb Haemost; 2016 Jan; 14(1):175-85. PubMed ID: 26559391
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
Scully M
Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
[TBL] [Abstract][Full Text] [Related]
35. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
36. [Thrombotic microangiopathy in adults].
Barrientos GJ; Michelangelo H
Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
[TBL] [Abstract][Full Text] [Related]
37. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Franchini M; Zaffanello M; Veneri D
Thromb Res; 2006; 118(2):177-84. PubMed ID: 16126255
[TBL] [Abstract][Full Text] [Related]
38. [Thrombotic microangiopathies].
Moulinier C; Veyradier A; Rondeau E; Coppo P;
Rev Prat; 2013 Feb; 63(2):163-70. PubMed ID: 23513771
[TBL] [Abstract][Full Text] [Related]
39. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
